Tandlægeselskabet Colosseum Slotsgade 18 Odense ApS — Credit Rating and Financial Key Figures
CVR number: 41211423
Slotsgade 18, 5000 Odense C
slotsgade@colosseumklinikken.dk
tel: 66119646
https://colosseumtand.dk/odense/slotsgade/
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 6 285.23 | 14 771.06 | 13 831.97 | 12 769.32 |
| Employee benefit expenses | -6 153.26 | -12 151.14 | -12 086.64 | -11 805.11 |
| Total depreciation | - 516.74 | -1 098.45 | -1 254.15 | -1 391.84 |
| EBIT | - 384.78 | 1 521.48 | 491.18 | - 427.62 |
| Other financial income | 7.24 | 3.89 | 2.57 | |
| Other financial expenses | - 108.78 | - 188.41 | - 130.04 | -80.34 |
| Pre-tax profit | - 486.31 | 1 336.95 | 361.14 | - 505.39 |
| Income taxes | - 206.00 | - 104.96 | - 131.70 | |
| Net earnings | - 486.31 | 1 130.95 | 256.18 | - 637.09 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Buildings | 267.68 | 426.07 | 526.39 | |
| Machinery and equipment | 3 634.57 | 4 274.74 | 3 745.07 | 2 820.33 |
| Tangible assets total | 3 634.57 | 4 542.41 | 4 171.14 | 3 346.73 |
| Other receivables | 396.00 | 404.00 | 404.00 | |
| Investments total | 396.00 | 404.00 | 404.00 | |
| Long term receivables total | ||||
| Raw materials and consumables | 173.34 | 149.47 | 125.96 | |
| Finished products/goods | 96.42 | |||
| Inventories total | 96.42 | 173.34 | 149.47 | 125.96 |
| Current trade debtors | 347.35 | 419.99 | 456.19 | 335.62 |
| Current owed by particip. interest comp. | 471.77 | 1 303.25 | ||
| Prepayments and accrued income | 44.46 | 168.69 | 88.91 | 108.25 |
| Current other receivables | 958.12 | 184.77 | 137.89 | 148.10 |
| Short term receivables total | 1 821.70 | 2 076.70 | 682.99 | 591.97 |
| Cash and bank deposits | 1 254.51 | 810.34 | 274.38 | 57.03 |
| Cash and cash equivalents | 1 254.51 | 810.34 | 274.38 | 57.03 |
| Balance sheet total (assets) | 6 807.20 | 7 998.79 | 5 681.98 | 4 525.69 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 644.00 | 256.18 | ||
| Retained earnings | -1 130.32 | - 255.54 | 0.64 | |
| Profit of the financial year | - 486.31 | 1 130.95 | 256.18 | - 637.09 |
| Shareholders equity total | - 446.31 | 684.64 | 296.81 | - 596.46 |
| Provisions | 120.70 | |||
| Non-current owed to participating | 2 938.33 | 2 078.33 | ||
| Non-current other liabilities | 387.75 | 387.75 | ||
| Non-current deferred tax liabilities | 391.07 | 369.53 | ||
| Non-current liabilities total | 3 326.08 | 2 466.08 | 391.07 | 369.53 |
| Advances received | 38.60 | 55.92 | 40.69 | 33.25 |
| Current trade creditors | 544.27 | 1 160.75 | 712.98 | 609.86 |
| Current owed to participating | 860.00 | 1 130.52 | ||
| Short-term deferred tax liabilities | 206.00 | 284.19 | 102.31 | |
| Other non-interest bearing current liabilities | 2 484.56 | 2 294.88 | 3 956.23 | 3 886.50 |
| Current liabilities total | 3 927.43 | 4 848.07 | 4 994.09 | 4 631.92 |
| Balance sheet total (liabilities) | 6 807.20 | 7 998.79 | 5 681.98 | 4 525.69 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.